2021 OPIOID PRESCRIBING AND ABUSE WEBINAR SERIES
Substance Use Disorder Treatment During Pregnancy
Accredited for 1.0 AMA PRA Category 1 Credits™
Thursday, April 8, 2021
Noon - 1:00 p.m. ET
Not a member? Join HERE.
The rates of substance use during pregnancy and substance use disorder (SUD) in pregnant and postpartum women have increased significantly in the past decade, and screening for substance use is recommended for all pregnant women during the first prenatal visit. Follow-up evaluation is necessary for those found to be at high risk for SUD, and maintaining a nonjudgmental approach during these discussions is critical. This webinar covers the importance of screening and the steps involved in ongoing treatment during and after pregnancy.
At the end of this webinar, attendees will be able to:
- Utilize screening for substance use during pregnancy as an opportunity to educate and change the lives of women and families.
- Understand that SUD is a chronic disease that requires lifelong treatment and management.
- Explain the universal verbal screening for SUD during pregnancy, reflex urine testing, and referral of pregnant women with SUD for treatment.
- Counsel pregnant women with SUD that maintenance therapy is recommended during pregnancy – not detoxification.
Mary Pell Abernathy, MD, MBA
Associate Professor of Clinical Obstetrics and Gynecology,
IU School of Medicine;
Chair, Indiana Maternal Mortality Review Committee
About the speaker:
Mary Pell Abernathy, MD, MBA, chairs the Indiana Maternal Mortality Review Committee and has worked with policymakers and legislators to prevent maternal and infant mortality in Indiana. She also leads the Indiana Perinatal Quality Collaborative (IPQIC) Reproductive Health Planning Task Force, which works to improve women’s care throughout their lives.
Dr. Abernathy completed her OB-GYN residency and maternal-fetal medicine fellowship at IU School of Medicine and her MBA at the IU Kelley School of Business. Her interests include using innovation to decrease maternal and infant mortality; medical education; prevention and treatment of preeclampsia; and preventing preterm births. She has received grants from the Indiana Department of Health and March of Dimes to study Centering Pregnancy and pregnancies complicated by obesity and gestational diabetes. She has also received grants from the Indiana Clinical and Translational Sciences Institute for research on preeclampsia.
Designation Statement: The Indiana State Medical Association (ISMA) designates this live webinar for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclosure: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial relationships with an “ineligible company” whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. None of the members of the CME Planning Committee or our speaker have any relevant financial relationships to disclose.
Note: While offering the CME credit hours listed in these pages, these activities are not intended to provide extensive training in a field.
Supported by an Educational Grant from:
If you have questions, contact ISMA Continuing Medical Education staff at 800-257-4762 or firstname.lastname@example.org.
REGISTRATION DEADLINE: April 8 @ 11 a.m. ET
REGISTRATION DETAILS - PLEASE NOTE:
Once registered, you will receive an immediate “Registration Confirmation” email containing dial in and web access information.